2BBBullish & Bearish
Avantor, Inc. Common Stock (AVTR) trades on NYSE. It operates in the Health Care sector, Medical Instruments & Supplies industry. Its current 2BB score is 55 out of 100.
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
Avantor, Inc. Common Stock’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 55 | Moderate |
| Momentum | 45 | Stable |
| Financial strength | 46 | Normal |
| Quality | 100 | Very Strong |
| Risk | 36 | Low |
| CEO | Emmanuel Ligner |
| Headquarters | Radnor Township, Pennsylvania, United States |
| Founded | 1904 |
| Employees | 13.5K |
| 52-week range | $7.26 – $15.93 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-09 | — | 0.2284 | — | $1.71B |
| 2026-10-27 | — | 0.2115 | — | $1.67B |
| 2026-07-29 | — | 0.1934 | — | $1.64B |
| 2026-04-29 | 0.17 | 0.1601 | $1.58B | $1.57B |